Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.61 -0.07 (-10.38%)
As of: Oct 21, 2026 · 1:53 PM EDT

Scinai Immunotherapeutics (SCNI) EV to EBITDA (2022)

Updated

Analysis

Scinai Immunotherapeutics (SCNI) EV to EBITDA (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn
2 Johnson & Johnson 616.11 Bn 534.64 Bn 17.26 Bn
3 AbbVie 501.21 Bn 474.32 Bn 12.70 Bn
4 Merck 367.51 Bn 321.89 Bn 12.21 Bn
5 Novartis Ag 297.95 Bn 261.94 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 235.88 Bn 191.28 Bn 7.24 Bn
8 Gilead Sciences 190.74 Bn 164.94 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 Scinai Immunotherapeutics 142,566.87 -8.12 Mn -1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 0.63
API Access

Scinai Immunotherapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=SCNI&period=max&api_key=YOUR_API_KEY